Major World Pancreatic Cancer Markets Analysed & Forecast in Black Swan Analysis Report Now Available at

11 Mar 2016 • by Natalie Aster

LONDON – Nowadays, cancer has become a real plague, it is one of key reasons for mortality in the world.

Currently, the global pancreatic cancer (PC) market grows at a relatively swift pace given existing unmet therapy needs. Being diagnosed in patients aged 75 (about 75% of cases), PC is known as a disease of predominantly elderly people.

A plenty of unmet therapy needs and inadequate results of treatments linked with the aggressive nature of PC are amid the top challenges that hamper the global PC market growth. Meanwhile, the revenues of the market are anticipated to grow at a moderate pace in the upcoming years.

The USA is a leader in the global PC market in terms of a number of PC patients. There are about 30,000 people are diagnosed with PC annually.

The research report “Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026” worked out by Black Swan Analysis limited presents an up-close discussion of the global pancreatic cancer (PC) market, paying special attention to the performance of key PC markets (17 in total). The research report contains the disease description, details on its main causes, risk factors and prevention, diagnosis, etc. The report comprises valuable data on current incidence and an overview of stages, histopathology and locations of PC tumors. Future market outlook till 2026 is on hand in the study, too.

Report Details:

Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026
Published: February, 2016
Pages: 54
Price: US$ 6,382.00

Many other research reports by the publisher are published at Black Swan Analysis limited page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970